Surrozen (SRZN) EPS (Weighted Average and Diluted) (QoQ) (2021 - 2026)
Surrozen (SRZN) EPS (Weighted Average and Diluted) (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Surrozen |
225,877.86 |
-106.68 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
51.21% |
| Dec 31, 2025 |
-185.65% |
| Sep 30, 2025 |
-427.84% |
| Jun 30, 2025 |
134.32% |
| Mar 31, 2025 |
18.35% |
| Dec 31, 2024 |
-1,968.18% |
| Sep 30, 2024 |
94.49% |
| Jun 30, 2024 |
-88.44% |
| Mar 31, 2024 |
2.97% |
| Dec 31, 2023 |
14.98% |
| Sep 30, 2023 |
-9.83% |
| Jun 30, 2023 |
34.64% |
| Mar 31, 2023 |
99.02% |
| Dec 31, 2022 |
-192,662.59% |
| Sep 30, 2022 |
5.00% |
| Jun 30, 2022 |
-73.91% |
| Mar 31, 2022 |
99.96% |
| Dec 31, 2021 |
-118,655.75% |
| Sep 30, 2021 |
26.09% |
